Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013527
Filing Date
2018-05-15
Accepted
2018-05-15 08:22:57
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q novn-10q_20180331.htm 10-Q 1324791
2 EX-31.1 novn-ex311_8.htm EX-31.1 17087
3 EX-31.2 novn-ex312_10.htm EX-31.2 17053
4 EX-32.1 novn-ex321_11.htm EX-32.1 11384
5 EX-32.2 novn-ex322_7.htm EX-32.2 11421
  Complete submission text file 0001564590-18-013527.txt   5707822

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT novn-20180331.xml EX-101.INS 1244813
7 XBRL TAXONOMY EXTENSION SCHEMA novn-20180331.xsd EX-101.SCH 47359
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE novn-20180331_cal.xml EX-101.CAL 32671
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE novn-20180331_def.xml EX-101.DEF 161034
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE novn-20180331_lab.xml EX-101.LAB 345228
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE novn-20180331_pre.xml EX-101.PRE 284238
Mailing Address 4105 HOPSON ROAD MORRISVILLE NC 27560
Business Address 4105 HOPSON ROAD MORRISVILLE NC 27560 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37880 | Film No.: 18833204
SIC: 2834 Pharmaceutical Preparations